Skip to main content
Journal of the Endocrine Society logoLink to Journal of the Endocrine Society
. 2026 Jul 1;10(7):bvag144. doi: 10.1210/jendso/bvag144

Correction to: “Diazoxide Choline Extended-Release (DCCR) Use in Prader–Willi Syndrome: Patient Selection, Dosing, and Management”

PMCID: PMC13320698  PMID: 42388364

In the above-named article by Miller JM, Shoemaker AH, Salehi P, and Mejia-Corletto, J (J Endo Society 2026; 10(6); doi: 10.1210/jendso/bvag099), there was an error in the section “When interactions are unavoidable.”

In the originally published article, in the section “When interactions are unavoidable,” the sentence reads, “If therapy is interrupted because of DDIs or AEs, treatment may be resumed at the prior dose if the interruption is ≥ 7 days.” In the corrected article, the sentence reads, “If therapy is interrupted because of DDIs or AEs, treatment may be resumed at the prior dose if the interruption is <7 days.”

The article has been corrected online.

doi: 10.1210/jendso/bvag099


Articles from Journal of the Endocrine Society are provided here courtesy of The Endocrine Society

RESOURCES